Antifungal composition

By using a combination of compositions A and B, the problems of insufficient biological activity and significant environmental impact of existing fungicides in the control of plant pathogenic fungi are solved, achieving more efficient and safer plant disease control.

CN115697063BActive Publication Date: 2026-11-17SYNGENTA CROP PROTECITON AG
View PDF 41 Cites 0 Cited by

Patent Information

Application Number
CN202180040155.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-06-03
Filing Date
2021-05-27
Publication Date
2026-11-17
Estimated Expiration
2041-05-27

AI Technical Summary

Technical Problem

Existing fungicides and compositions are insufficient to meet the needs of agricultural practice in controlling plant pathogenic fungi, for example, due to insufficient biological activity, limited activity spectrum, poor crop tolerance, poor synergistic effect, multiple application times, significant environmental impact, and high risk of exposure to operators.

Method used

A composition of fungicidal compounds with different modes of action is used, wherein component (A) is a compound with a specific structure and component (B) is a mixture selected from a variety of known fungicides. The weight ratio and application method are optimized to enhance biological activity, improve the activity spectrum and crop tolerance.

Benefits of technology

It provides effective control of plant pathogenic fungi, improves biological activity and crop tolerance, reduces the number of applications and environmental impact, and reduces the exposure risk to operators.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

Disclosed is an antifungal composition comprising a mixture of components (A) and (B), wherein components (A) and (B) are as defined in claim 1, and the use of said composition in agriculture or horticulture for controlling or preventing plant infection by plant pathogenic microorganisms, preferably fungi.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This invention relates to novel antifungal compositions, their use in agriculture or horticulture for controlling diseases caused by plant pathogens (especially plant pathogenic fungi), and methods for controlling diseases on beneficial plants.

[0002] WO 2010 / 012793, WO 2017 / 207362 and WO 2019 / 105933 describe thiazole derivatives as pest control agents.

[0003] Although many fungicidal compounds and compositions belonging to various chemical classes have been developed or are being developed for use as fungicides in beneficial plant crops, crop tolerance and activity against specific plant pathogens do not always meet the needs of agricultural practice in many respects. Therefore, there is a persistent need to discover new compounds and compositions with superior biological properties for the control or prevention of plant infection by plant pathogens. For example, compounds with greater biological activity, favorable activity spectra, increased safety, improved physicochemical properties, or increased biodegradability; or, alternatively, compositions with broader activity spectra, improved crop tolerance, improved synergistic interactions or enhancing properties, or compositions exhibiting faster onset of action or longer residual activity, or compositions that reduce the number of applications and / or application rate required for effective control of plant pathogens, thereby enabling beneficial tolerance management practices, reducing environmental impact, and reducing operator exposure.

[0004] Some of these needs can be addressed by using compositions comprising mixtures of different fungicidal compounds with different modes of action (e.g., by combining fungicides with different activity spectra).

[0005] According to the present invention, an antifungal composition is provided, the composition comprising a mixture of components (A) and (B) as an active ingredient, wherein component (A) is a compound having formula (I):

[0006]

[0007] in

[0008] X is N;

[0009] Y is either CF or CH;

[0010] R 1It is hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 hydroxyalkyl, C1-C3 alkoxy C1-C4 alkyl, C3-C4 cycloalkyl, C1-C2 alkoxy C1-C2 alkoxy, C1-C3 alkoxy carbonyl C1-C3 alkyl, C1-C2 alkoxy carbonyloxy C1-C2 alkyl, C1-C2 alkyl carbonyloxy C1-C2 alkyl, C3-C4 alkynyloxy, C1-C3 alkyl thioalkyl, diethylamino, phenyl, benzyl, phenoxy, benzyloxy C1-C2 alkyl, thiophene, or furanyl;

[0011] R 2 It is a C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or HC(O)NH-;

[0012] R 3 It is a C3-C6 cycloalkyl group, wherein the cycloalkyl group is optionally composed of one or two R groups. 4 The group substitution, or R 3 It is a 6- to 10-element non-aromatic spirocyclic carbon bicyclic system;

[0013] R 4 It is a C1-C3 alkyl group;

[0014] or its salts or N-oxides; and

[0015] Component (B) is a compound selected from the group consisting of:

[0016] Azoxystrobin, oxadiazon, azoxystrobin, pyraclostrobin, eugenol, metyltetraprole, cycloconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, cyclophosphamide, prothioconazole, chlorfluazuron, prochloraz, benzalkonium chloride, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzovindiflupyr, fluopyram, isoflucypram, bifenpyraclostrobin, pyrapropoyne, inpyrfluxam, pyrapropoyne, fluopyram, fenpicoxam id), florylpicoxamid, aramid-type benzene-S-methyl, anti-rot ester, aluminum triethylphosphonate, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, isobutylethoxyquinoline, trifluoromethoxycarb, tricyclazole, cycloquinone, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be derived from WO (Prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be prepared by the method described in WO 2016 / 202688); N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (this compound can be prepared by the method described in WO 2016 / 202688); N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, (these compounds can be prepared by the method described in WO 2016 / 202688); N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, (these compounds can be prepared by the method described in WO 2016 / 202742); N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl- Prepared by the method described in 2017 / 153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, (these compounds can be prepared by WO Prepared by the method described in WO 2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, (these compounds can be prepared by the method described in WO 2016 / 156085);N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium (these compounds can be prepared by the method described in WO 2015 / 155075); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium (this compound can be prepared by WO 2015 / 155075) Prepared by the method described in 2018 / 228896); N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide [[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (these compounds can be derived from WO4) Prepared by the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689;(Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (these compounds can be derived from WO Prepared by the method described in 2020 / 079111); methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, ( Methyl (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methylphenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazolyl)-2-methylphenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoate, (i.e., Bacillus amyloliquefaciens strain FZB24), Timorex Gold TM (Plant extracts containing tea tree oil), and metarylpicoxamid.

[0017] Typically, the weight ratio of component (A) to component (B) can preferably be from 100:1 to 1:100, from 50:1 to 1:50, from 20:1 to 1:40, from 15:1 to 1:30, from 12:1 to 1:25, from 10:1 to 1:20, from 5:1 and 1:15, from 3:1 to 1:10, or from 2:1 to 1:5.

[0018] In addition, according to the present invention, a method for controlling or preventing plant pathogenic diseases, especially plant pathogenic fungi, on useful plants or their propagation material is provided, the method comprising applying a fungicidal composition according to the present invention to such useful plants, their sites or their propagation material.

[0019] The benefits provided by certain fungicidal mixture compositions according to the invention may also include, in particular, favorable levels of bioactivity for protecting plants against fungal diseases or superior properties for use as active ingredients in agrochemicals (e.g., greater bioactivity, favorable activity spectrum, increased safety, improved physicochemical properties, or increased biodegradability).

[0020] The presence of one or more possible asymmetric carbon atoms in a compound having formula (I) means that the compound can exist in optical isomeric form (i.e., enantiomers or diastereomers). As a result of restricted rotation around the single bond, transisomers may also exist. This invention includes all those possible isomeric forms (e.g., geometric isomers) of compounds having formula (I) and mixtures thereof. This invention includes all possible tautomeric forms of compounds having formula (I), and also includes racemic compounds, i.e., mixtures of at least two enantiomers in a substantially 50:50 ratio.

[0021] In each case, the compound of formula (I) according to the invention is in a free form, an oxidized form such as an N-oxide, or a salt form (e.g., an agronomically usable salt form).

[0022] N-oxides are the oxidized forms of tertiary amines or nitrogen-containing heteroaromatic compounds. For example, they are described by A. Albini and S. Pietra in their 1991 book, "Heterocyclic N-oxides," published by CRC Press in Boca Raton.

[0023] The preferred groups and values ​​of substituents in compounds having formula (I), in any combination thereof, are listed below.

[0024] Y is either CF or CH. In one set of embodiments, Y is CF. In another set of embodiments, Y is CH.

[0025] X is N.

[0026] R 1 It is hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl, C1-C3 hydroxyalkyl, C1-C3 alkoxy C1-C4 alkyl, C3-C4 cycloalkyl, C1-C2 alkoxy C1-C2 alkoxy, C1-C3 alkoxy carbonyl C1-C3 alkyl, C1-C2 alkoxy carbonyloxy C1-C2 alkyl, C1-C2 alkyl carbonyloxy C1-C2 alkyl, C3-C4 alkynyloxy, C1-C3 alkyl thioalkyl, diethylamino, phenyl, benzyl, phenoxy, benzyloxy C1-C2 alkyl, thiophene, or furanyl.

[0027] Preferably, R 1 It is hydrogen, methyl, ethyl, isopropyl, methoxy, ethoxy, fluoromethyl, chloromethyl, bromomethyl, 2,2,2-trifluoroethyl, 1-hydroxyethyl, methoxymethyl, 1-methoxyethyl, 1-ethoxymethyl, 1-methoxy-1-methylethyl, cyclopropyl, methoxyethoxy, ethoxycarbonyl, 2-methoxy-2-oxo-ethyl, 2-methoxy-oxo-ethyl, 2-methoxy-oxo-propyl, propyneoxy, 1-methoxycarbonyloxy-ethyl, 1-ethoxycarbonyloxy-ethyl, 1-methylcarbonyloxy-ethyl, methylcarbonyloxymethyl, methylthioalkyl, ethylthioalkyl, isopropylthioalkyl, diethylamino, phenyl, benzyl, phenoxy, benzyloxymethyl, 1-benzyloxyethyl, 2-furanyl, or 2-phenylthio.

[0028] More preferably, R 1 It is hydrogen, methyl, ethyl, isopropyl, methoxy, ethoxy, fluoromethyl, 2,2,2-trifluoroethyl, 1-hydroxyethyl, 1-ethoxymethyl, cyclopropyl, methoxyethoxy, 2-methoxy-2-oxo-ethyl, 2-methoxy-oxo-ethyl, 2-methoxy-oxo-propyl, propargyloxy, 1-methoxycarbonyloxy-ethyl, 1-ethoxycarbonyloxy-ethyl, 1-methylcarbonyloxy-ethyl, methylcarbonyloxymethyl, isopropylthioalkyl, diethylamino, phenyl, benzyl, phenoxy, benzyloxymethyl, 1-benzyloxyethyl, 2-furanyl, or 2-phenylthio.

[0029] R 2 It is a C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, or HC(O)NH-. Preferably, R 1 It is a C1-C3 alkyl or C1-C3 alkoxy. More preferably, R 1 It is methyl or methoxy.

[0030] R 3 It is a C3-C6 cycloalkyl group, wherein the cycloalkyl group is optionally composed of one or two R groups. 4 The group substitution, or R 3 It is a 6- to 10-element non-aromatic spirocyclic carbon bicyclic system.

[0031] Preferably, R 3 It is a C3-C4 cycloalkyl group, wherein the cycloalkyl group is optionally composed of one or two R groups. 4 The group substitution, or R 3 It is a 6- to 8-member non-aromatic spirocyclic carbon bicyclic system.

[0032] More preferably, R 3It is cyclobutyl, 2,2-dimethylcyclobutyl or spiro[3,4]octyl, and most preferably cyclobutyl, 2,2-dimethylcyclobutyl or spiro[3,4]octyl-3-yl.

[0033] R 4 It is a C1-C3 alkyl group. Preferably, R 4 It is methyl, ethyl, or isopropyl. More preferably, R 4 It is a methyl group.

[0034] Preferably, component (A) is a compound selected from the following:

[0035] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate (compound X.01);

[0036] [2-[[4-(cyclobutylcarbamoyl)-5-methyl-thiazolyl-2-yl]-(2,6-difluoro-4-pyridinyl)amino]-1-methyl-2-oxo-ethyl] ethyl carbonate (compound X.02);

[0037] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]methyl carbonate (compound X.03);

[0038] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]ethyl carbonate (compound X.04);

[0039] 2-[(2,6-difluoro-4-pyridinyl)-(2-hydroxypropionyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.05);

[0040] 2-[2-benzyloxypropionyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.06);

[0041] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazolyl-4-carboxamide (Compound X.07);

[0042] [2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-2-oxo-ethyl]acetate (compound X.08);

[0043] 2-[(2,6-difluoro-4-pyridyl)-(2-phenylacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.09);

[0044] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methoxy-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.10);

[0045] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.11);

[0046] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.12);

[0047] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.13);

[0048] 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.14);

[0049] 2-[(2,6-difluoro-4-pyridinyl)-(2-ethoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.15);

[0050] 2-[diethylcarbamoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.16);

[0051] 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.17);

[0052] 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionic acid methyl ester (compound X.18);

[0053] 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.19);

[0054] 5-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-5-oxo-valerate methyl ester (compound X.20);

[0055] 2-[(2,6-difluoro-4-pyridinyl)-(3,3,3-trifluoropropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.21);

[0056] SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl]isopropyl thiocarbamate (compound X.22);

[0057] 4-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-4-oxo-butyrate methyl ester (compound X.23);

[0058] 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.24);

[0059] 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.25);

[0060] N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate (compound X.26);

[0061] 2-[(2,6-difluoro-4-pyridinyl)-(2-fluoroacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.27);

[0062] N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl]carbamate 2-methoxyethyl ester (compound X.28);

[0063] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.29);

[0064] N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate (compound X.30);

[0065] 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.31);

[0066] N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl]carbamate (compound X.32);

[0067] 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.33);

[0068] 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]amino]-2-oxo-ethyl acetate (compound X.34);

[0069] 2-[benzoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.35);

[0070] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.36);

[0071] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37); and

[0072] 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (X.38).

[0073] More preferably, component (A) is a compound selected from the following:

[0074] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate (compound X.01);

[0075] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]ethyl carbonate (compound X.04);

[0076] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazolyl-4-carboxamide (Compound X.07);

[0077] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.11);

[0078] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.12);

[0079] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.13);

[0080] 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.14);

[0081] 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.17);

[0082] 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionic acid methyl ester (compound X.18);

[0083] 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.19);

[0084] SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl]isopropyl thiocarbamate (compound X.22);

[0085] 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.24);

[0086] N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate (compound X.26);

[0087] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.29);

[0088] 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.31);

[0089] 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.33);

[0090] 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]amino]-2-oxo-ethyl acetate (compound X.34);

[0091] 2-[benzoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.35);

[0092] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.36);

[0093] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37); and

[0094] 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (X.38).

[0095] Even more preferably, component (A) is selected from compounds including:

[0096] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate (compound X.01);

[0097] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]ethyl carbonate (compound X.04);

[0098] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.11);

[0099] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.12);

[0100] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.13);

[0101] 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.17);

[0102] 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionic acid methyl ester (compound X.18);

[0103] 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.19);

[0104] 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.24);

[0105] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.29);

[0106] 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.33);

[0107] 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]amino]-2-oxo-ethyl acetate (compound X.34);

[0108] 2-[benzoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.35);

[0109] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.36);

[0110] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37); and

[0111] 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (X.38).

[0112] More preferably, component (A) is a compound selected from the following:

[0113] [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate (compound X.01);

[0114] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.11);

[0115] N-Cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazolyl-4-carboxamide (compound X.12);

[0116] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide (compound X.13);

[0117] 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.19);

[0118] 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.29);

[0119] 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.33);

[0120] 2-[benzoyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.35);

[0121] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.36);

[0122] 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37); and

[0123] 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (X.38).

[0124] Table X

[0125]

[0126]

[0127]

[0128]

[0129]

[0130]

[0131]

[0132] Preferably, component (B) is a compound selected from the group consisting of:

[0133] Azoxystrobin, oxadiazon, azoxystrobin, pyraclostrobin, eugenol, metyltetraprole, cycloconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, cyclophosphamide, prothioconazole, chlorfluazuron, prochloraz, benzyl methoxyfenozide, benzoyl methoxyfenozide, fluopyram, fluopyram, pyrapropoyne, fluopyram, benzoyl methoxyfenozide, fluopyram, isoflucypram, bifenthiophanate-methyl, pyrapropoyne, fluopyram, florylpicoxamid, aramacin-S-methyl, anti-rot ester, aluminum tris(ethyl phosphonate), chlorothalonil, mancozeb, diyrylamide Amines, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, isobutylethoxyquinoline, trifluoromethoxycarb, tricyclazole, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline 3-Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5 ...8-fluoro-quinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-8-fluoro-quinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-8-fluoro-quinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-8-fluoro-quinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-8-fluoro-quinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-8-fluoro-quin N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]propyl 2-Oleic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, ( Methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoate.

[0134] In another set of embodiments, component (B) is selected from the group consisting of:

[0135] Azoxystrobin, oxadiazon, azoxystrobin, pyraclostrobin, eugenol, metyltetraprole, cycloconazole, tebuconazole, difenoconazole, hexaconazole, propiconazole, cyclophosphamide, prothioconazole, chlorfluazuron, prochloraz, benzyl methoxyfenozide, benzoyl methoxyfenozide, fluopyram, fluopyram, pyrapropoyne, fluopyram, benzoyl methoxyfenozide, fluopyram, isoflucypram, bifenthiophanate-methyl, pyrapropoyne, fluopyram, florylpicoxamid, aramacin-S-methyl, anti-rot ester, aluminum tris(ethyl phosphonate), chlorothalonil, mancozeb, dimethomorph Thiapaveril, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, isobutylethoxyquinoline, trifluoromethoxycarb, tricyclazole, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline- 3-Carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-8-fluoro-quinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-8-fluoro-quinoline, 1-(6,7-dimethylbenzimidazol-1-yl)-8-fluoro-quinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3 ... N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-Trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethyl oxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy] Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl)phenoxy]methyl propionate, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate Methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-cyclohexylthiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-[4-(ethoxymethyl)thiazo-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-2-[5-(4-bromothiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazo-2-yl]phenoxy]prop-2-enoate, Timorex Gold TM And metarylpicoxamid.

[0136] More preferably, component (B) is a compound selected from the group consisting of:

[0137] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyraclostrobin, fluoxastrobin, benzyl hydroxylamine, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofume lin, tricyclazole, quinolones, cycloflufenoxam, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5 -Trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl) [5-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-] (trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazole-1-yl] Methyl propionate (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methylphenoxy]-3-methoxy-propionate (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propionate (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propionate (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxy-propionate (Z)-2-(5-cyclopentyl-2-methylphenoxy) Methyl 3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methylphenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methylphenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-bromothiazolyl)-2-methylphenoxy]-3-methoxy-propane-2-enoate, and (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]propane-2-enoate.

[0138] In another set of embodiments, component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron-methyl, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluopyram, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, fludioxonil, azoxystrobin, metalaxyl-M, aminopyrifen. , Sterilant, ipflufenoquin, quinofumelin, tricyclazole, cycloquinone, cycloflufenazate, benomyl, N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl) -yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-Oxadiazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3 -Ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazole-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5- Methyl propylpyrazole-1-yl)phenoxy]prop-2-enoate, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxy-prop-2-enoate, (Z)-2-(5-cyclopentyl-2-yl)-2-[5-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate, (Z)-2-(5-cyclopentyl-2-yl)-2-[5-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate Methyl 3-methoxy-prop-2-enoate (Z)-2-[5-(4-cyclohexylthiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl 3-methoxy-prop-2-enoate (Z)-2-[5-[4-(ethoxymethyl)thiazo-2-yl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl 3-methoxy-2-[5-(4-bromothiazo-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate, methyl 3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazo-2-yl]phenoxy]prop-2-enoate, Timorex Gold TM And metarylpicoxamid.

[0139] More preferably, component (B) is a compound selected from the group consisting of:

[0140] Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyrazosulfuron, fluoxastrobin, benzyl-methyl, fluoxastrobin, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrapropoyne, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber. N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

[0141] In a particularly preferred set of embodiments, component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflubenzuron, fluopyram, isoflucypram, isopropyram, pyrapropoy ne, fluopyram, benzylpyridinium, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1 -Benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop- 2-Ocenoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy [4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4- [5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and ethyl pyrazole-4-carboxylate.

[0142] These component (B) compounds are referred to herein and above by their so-called "ISO common name" or another "common name" or trademark name, as used in individual cases. These component (B) compounds are known and commercially available and / or can be prepared using procedures known in the art and / or procedures reported in the literature.

[0143] In a preferred composition according to the invention, component (A) is compound number X.01, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram. Amines, fluopyram, pyrapropoyne, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2] [-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine- 3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0144] In another preferred composition according to the invention, component (A) is compound number X.04, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl] ethyl carbonate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluorinated azoxystrobin Azoxystrobin, fluopyram, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'- [2-Chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine 1-(6,7-dimethylpyrazol[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0145] In another preferred composition according to the invention, component (A) is compound number X.07, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0146] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0147] In another preferred composition according to the invention, component (A) is compound number X.12, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0148] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymecium benzoate, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0149] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0150] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyridaben Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0151] In another preferred composition according to the invention, component (A) is compound number X.18, methyl 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, and fluoroquinolones. Pyraclostrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro] [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3 1-(6,7-dimethylpyrazol-3,3-dimethyl-1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0152] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0153] In another preferred composition according to the invention, component (A) is compound number X.22, SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]thiocarbamate isopropyl ester or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram Azoxystrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquin, benomyl, N'-[2-chloro- [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3- 1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazol[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0154] In another preferred composition according to the invention, component (A) is compound number X.24, 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0155] In another preferred composition according to the invention, component (A) is compound number X.26, N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0156] In another preferred composition according to the invention, component (A) is compound number X.29, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0157] In another preferred composition according to the invention, component (A) is compound number X.31, 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0158] In another preferred composition according to the invention, component (A) is compound number X.33, 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0159] In another preferred composition according to the invention, component (A) is compound number X.34, 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-2-oxo-ethyl acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, and fluoroquinolones. Pyraclostrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro] [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3 1-(6,7-dimethylpyrazol-3,3-dimethyl-1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0160] In another preferred composition according to the invention, component (A) is compound number X.35, 2-[benzoyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0161] In another preferred composition according to the invention, component (A) is compound number X.36, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0162] In another preferred composition according to the invention, component (A) is compound number X.37, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]propyl-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]propyl-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenyl Methyl 3-methoxy-propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]propane-2-enoate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]propane-2-enoate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-propane-2-enoate, (Z)-2-[5-(4-cyclohexylthiazolyl)-2-methyl-phenoxy]-3-methoxy-propane-2-enoate, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]- 2-Methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazol-2-yl)-2-methylphenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, bifenthiazide, aluminum tris(ethyl phosphonate), Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0163] In another preferred composition according to the invention, component (A) is compound number X.38, 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyloxydine, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-bromothiazolyl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazolyl]phenoxy]prop-2-enoic acid methyl ester, Timorex Gold TM And metarylpicoxamid, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0164] In a more preferred composition according to the invention, component (A) is compound number X.01, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxime ester, metyltetra Prole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzyl-methyl, fluoxastrobin, isoflucypram, pyrapropoyne, fluopyram, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, pyrimethanil, pyrimethanil, pyrimethanil Cycloamine, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-Benzyl-1,3-Dimethyl-Butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-Benzyl-3,3,3-Trifluoro-1-Methyl-Propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-Dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trimethylpyrazol ... Fluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0165] In another preferred composition according to the invention, component (A) is compound number X.04, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl] ethyl carbonate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxime ester, metyltet raprole, difenoconazole, hexaconazole, propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluopyram, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, pyrimethanil, pyrimethanil, pyrimethanil Cyclomethasone, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhein, N-(1-Benzyl-1,3-Dimethyl-Butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-Benzyl-3,3,3-Trifluoro-1-Methyl-Propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-Dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5- The following are listed: trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0166] In another preferred composition according to the invention, component (A) is compound number X.07, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0167] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0168] In another preferred composition according to the invention, component (A) is compound number X.12, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3 -Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0169] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-cyclobutyl-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Thiophanate, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, amino Pyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-di Methyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0170] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0171] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Azoxystrobin, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl- M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0172] In another preferred composition according to the invention, component (A) is compound number X.18, methyl 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionate or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxime ester, metyltetraprol e. Difenoconazole, Hexaconazole, Propiconazole, Prothioconazole, Chlorfluazuron, Benzoic acid, Butylmorpholine, Fluopyram, Fluopyram, Pyrazosulfuron, Fluopyram, Benzoylfluopyram, Fluopyram, Isoflucypram, Pyrapropoyne, Fluopyram, Benzopyram, Florylpicoxamid, Chlorothalonil, Mancozeb, Dimethomorph, Thiabenazol, Fluazinam, Fludioxonil, Fludioxonil, Azoxystrobin Metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro -3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0173] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0174] In another preferred composition according to the invention, component (A) is compound number X.22, SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]thiocarbamate isopropyl ester or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oximetrimethoprim, metyltetraprole, etc. Difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, pyraclostrobin, pyrimethanil, methyl methoxyfenozide Aminopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro- 3,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0175] In another preferred composition according to the invention, component (A) is compound number X.24, 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, etc. Hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0176] In another preferred composition according to the invention, component (A) is compound number X.26, N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0177] In another preferred composition according to the invention, component (A) is compound number X.29, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0178] In another preferred composition according to the invention, component (A) is compound number X.31, 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, and difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0179] In another preferred composition according to the invention, component (A) is compound number X.33, 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, and hexazol. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0180] In another preferred composition according to the invention, component (A) is compound number X.34, 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-2-oxo-ethyl acetate or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of pyraclostrobin, oxime ester, metyltetraprol e. Difenoconazole, Hexaconazole, Propiconazole, Prothioconazole, Chlorfluazuron, Benzoic acid, Butylmorpholine, Fluopyram, Fluopyram, Pyrazosulfuron, Fluopyram, Benzoylfluopyram, Fluopyram, Isoflucypram, Pyrapropoyne, Fluopyram, Benzopyram, Florylpicoxamid, Chlorothalonil, Mancozeb, Dimethomorph, Thiabenazol, Fluazinam, Fludioxonil, Fludioxonil, Azoxystrobin Metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro -3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0181] In another preferred composition according to the invention, component (A) is compound number X.35, 2-[benzoyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, difenoconazole, and hexazinazole. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0182] In another preferred composition according to the invention, component (A) is compound number X.36, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0183] In another preferred composition according to the invention, component (A) is compound number X.37, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinoline, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3, 3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0184] In another preferred composition according to the invention, component (A) is compound number X.38, 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole. Picloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, pyrimethanil, metalaxyl -M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3 ,3-Dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30.

[0185] In a preferred composition according to the invention, component (A) is compound number X.01, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram. Amines, fluopyram, pyrapropoyne, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2] [-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine- 3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0186] In another preferred composition according to the invention, component (A) is compound number X.04, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl] ethyl carbonate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluorinated azoxystrobin Azoxystrobin, fluopyram, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'- [2-Chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine 1-(6,7-dimethylpyrazol[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0187] In another preferred composition according to the invention, component (A) is compound number X.07, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0188] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0189] In another preferred composition according to the invention, component (A) is compound number X.12, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, etc. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramid-S-methyl, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluorobenzyl)] [4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0190] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram. Benzoflufenicol, fluopyram, isoflucypram, pyrapropoyne, fluopinazole, benzymecium benzoate, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenicol, benomyl, N'-[2-chloro-4-(2-fluorophenoxy] [-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4, 4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0191] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0192] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyridaben Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquinone, benomyl, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0193] In another preferred composition according to the invention, component (A) is compound number X.18, methyl 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, and fluoroquinolones. Pyraclostrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro] [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3 1-(6,7-dimethylpyrazol-3,3-dimethyl-1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0194] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0195] In another preferred composition according to the invention, component (A) is compound number X.22, SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]thiocarbamate isopropyl ester or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram Azoxystrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinolones, cycloflufenoquin, benomyl, N'-[2-chloro- [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3- 1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazol[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0196] In another preferred composition according to the invention, component (A) is compound number X.24, 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Azoxystrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0197] In another preferred composition according to the invention, component (A) is compound number X.26, N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0198] In another preferred composition according to the invention, component (A) is compound number X.29, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, fluopyram. Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4- [(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0199] In another preferred composition according to the invention, component (A) is compound number X.31, 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0200] In another preferred composition according to the invention, component (A) is compound number X.33, 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0201] In another preferred composition according to the invention, component (A) is compound number X.34, 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-2-oxo-ethyl acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butylmorpholine, fluopyram, and fluoroquinolones. Pyraclostrobin, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluoxastrobin hydroxylamine, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, cycloflufenoquinone, cycloflufenoquinone, benomyl, N'-[2-chloro] [4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine-3 1-(6,7-dimethylpyrazol-3,3-dimethyl-1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0202] In another preferred composition according to the invention, component (A) is compound number X.35, 2-[benzoyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazol, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrazosulfuron. Amines, fluoxastrobin, benzylfluopyram, fluoxastrobin, isoflucypram, pyrapropoyne, fluoxastrobin, benzylpyridinium, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiberene, cyclofluopyram, benomyl, N'-[2-chloro-4-(2- [Fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) -4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-33-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0203] In another preferred composition according to the invention, component (A) is compound number X.36, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0204] In another preferred composition according to the invention, component (A) is compound number X.37, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin. Fluoxadiazon, benzovindiflupyr, fluoxadiazon, isoflucypram, pyrapropoyne, fluoxadiazon, benzymemid, florylpicoxamid, aramacin-S-methyl, chlorothalonil, mancozeb, diyrylamide, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofiber, cycloflufenoquinone, benomyl, N'-[2-chloro-4-(2-fluoro) [4-(2-bromophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)- 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0205] In another preferred composition according to the invention, component (A) is compound number X.38, 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyloxydine, butylmorpholine, fluopyram, fluopyram, Pyrazosulfuron, Fluopyram, Benzofluzoxystrobin, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxamid, Benzopyram, Florylpicoxamid, Aramaic acid-S-methyl, Chlorothalonil, Mancozeb, Diyrylamide, Thiabenazol, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofumelin, Tricyclazole, Fluquinone, Cyclofluzoxystrobin, Benzophenone, N'-[2-chloro-4-( [2-fluorophenoxy]-5-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N'-[4-(2-bromophenoxy)-5-chloro-2-methyl-phenyl]-N-ethyl-N-methyl-formamidinium, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl) 4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-Dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-... [Ethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)] -1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea [3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-Triazol-3-amine, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy Methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]methyl propionate, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]methyl propionate, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-propionate , (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(4-cyclohexylthiazolyl-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-[4-(ethoxymethyl)thiazolyl]-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z Methyl 2-[5-(4-bromothiazol-2-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoate and methyl (Z)-3-methoxy-2-[2-methyl-5-[5-(trifluoromethyl)thiazol-2-yl]phenoxy]prop-2-enoate, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0206] In a preferred composition according to the invention, component (A) is compound number X.01, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl]acetate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oximetrimethoprim, metyltetraprole, Difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, a Minopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyroquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0207] In another preferred composition according to the invention, component (A) is compound number X.04, [2-[(2,6-difluoro-4-pyridyl)-[5-methyl-4-(spiro[3,4]octane-3-ylcarbamoyl)thiazo-2-yl]amino]-1-methyl-2-oxo-ethyl] ethyl carbonate or a salt thereof, enantiomer, tautomer or N-oxide, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxime ester, metyltetrapro Le, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluopyram, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M Aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0208] In another preferred composition according to the invention, component (A) is compound number X.07, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxypropionyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0209] In another preferred composition according to the invention, component (A) is compound number X.11, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexazon... Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0210] In another preferred composition according to the invention, component (A) is compound number X.12, N-cyclobutyl-2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrif en, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0211] In another preferred composition according to the invention, component (A) is compound number X.13, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-cyclobutyl-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, etc. Chlorpyrimethanil, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, and other fungicides. Mancozeb, ipflufenoquin, quinofumelin, tricyclazole, pyrrolidone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro -3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0212] In another preferred composition according to the invention, component (A) is compound number X.14, 2-[(2-benzyloxyacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, and hexazol. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0213] In another preferred composition according to the invention, component (A) is compound number X.17, 2-[(2-chloroacetyl)-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole. Propiconazole, thiophanate-methyl, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyridaben Rifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rhodiola, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4 -Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0214] In another preferred composition according to the invention, component (A) is compound number X.18, methyl 3-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-3-oxo-propionate or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oximetrimethoate, metyltetraprole, methyl benzoate Cycloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0215] In another preferred composition according to the invention, component (A) is compound number X.19, 2-[(2,6-difluoro-4-pyridinyl)-(furan-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0216] In another preferred composition according to the invention, component (A) is compound number X.22, SN-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]thiocarbamate isopropyl ester or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, and difenoconazole. Azoxystrobin, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, amin opyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0217] In another preferred composition according to the invention, component (A) is compound number X.24, 2-[cyclopropanecarbonyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, etc. Cycloazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyr ifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4 -Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0218] In another preferred composition according to the invention, component (A) is compound number X.26, N-(2,6-difluoro-4-pyridyl)-N-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazolyl-2-yl]carbamate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, difenoconazole, and hexazinazole. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0219] In another preferred composition according to the invention, component (A) is compound number X.29, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, and hexazol. Azoxystrobin, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0220] In another preferred composition according to the invention, component (A) is compound number X.31, 2-[(2,6-difluoro-4-pyridinyl)-(thiophene-2-carbonyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0221] In another preferred composition according to the invention, component (A) is compound number X.33, 2-[(2,6-difluoro-4-pyridinyl)-formyl-amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrimethanil fen, sterilizing cap, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0222] In another preferred composition according to the invention, component (A) is compound number X.34, 2-[(2,6-difluoro-4-pyridyl)-[4-[(2,2-dimethylcyclobutyl)carbamoyl]-5-methyl-thiazo-2-yl]amino]-2-oxo-ethyl acetate or a salt, enantiomer, tautomer, or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxamyl ester, metyltetraprole, and difenoconazole. Cycloazole, hexaconazole, propiconazole, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, ami Nopyrifen, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0223] In another preferred composition according to the invention, component (A) is compound number X.35, 2-[benzoyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrimethanil fen, sterilizing cap, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0224] In another preferred composition according to the invention, component (A) is compound number X.36, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrimethanil fen, sterilizing cap, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0225] In another preferred composition according to the invention, component (A) is compound number X.37, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole Azoxystrobin, prothioconazole, chlorpyrifos, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrimethanil fen, sterilizing cap, ipflufenoquin, quinofumelin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4- Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0226] In another preferred composition according to the invention, component (A) is compound number X.38, 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaazole Alcohol, propiconazole, prothioconazole, chlorfenapyr, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluopyram, benzovindiflupyr, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminop Yrifen, Sterilizer, Ipflufenoquin, Quinofumelin, Tricyclazole, Rheoquinone, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4, 4-Difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10 (or even more preferably, 5:1 to 1:5).

[0227] In the preferred composition according to the invention, component (A) is compound number X.29, 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfenapyr, etc. Benzoic acid, butylmorpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzylfluopyram, fluopyram, isoflucypram, pyrapropoyne, fluindazole, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fluazinam, fludioxonil, pyrimethanil, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofu melin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazol[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazol[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa] [Diazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably, from 5:1 to 1:5.

[0228] In another preferred composition according to the invention, component (A) is compound number X.36, 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazuron, benzyl sulfadiazine , Butyram, Fluopyram, Fluopyram, Pyrazosulfuron, Fluopyram, Benzoylfluopyram, Fluopyram, Isoflucypram, Pyrapropoyne, Fluopyram, Benzopyram, Florylpicoxamid, Chlorothalonil, Mancozeb, Dimethomorph, Thiabenazol, Fluazinam, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofume lin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5- Dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa] [Diazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably, from 5:1 to 1:5.

[0229] In the preferred composition according to the invention, component (A) is compound number X.38, 2-[(2,6-difluoro-4-pyridinyl)-(2-methylpropionyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide or a salt, enantiomer, tautomer or N-oxide thereof, and component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzylpyridinium chloride, etc. Rust-pyrrolidone, Butylmorpholine, Fluopyram, Fluopyram, Pyrazosulfuron, Fluopyram, Benzoylfluopyram, Fluopyram, Isoflucypram, Pyrapropoyne, Fluindoxam, Benzopyram, Florylpicoxamid, Chlorothalonil, Mancozeb, Dimethomorph, Thiabenazole, Fluazinam, Fluazinam, Fludioxonil, Azoxystrobin, Metalaxyl-M, Aminopyrifen, Captan, Ipflufenoquin, Quinofum elin, tricyclazole, pyrrolizidine, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methylformamidinium, N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methylformamidinium, Timorex Gold™, Aramaic acid benzene-S-methyl, Cyclofluoromethane, Benomyl, Aluminum triethylphosphonate, metarylpicoxamid, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-(5-cyclopentyl- 2-Methyl-phenoxy)-3-methoxy-prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazole-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoic acid methyl ester, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxa] [Diazol-3-yl]phenyl]methyl]cyclopropane formamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propionamide, 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1, 2,4-Oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, and 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylic acid ethyl ester, wherein the weight ratio of component (A) to component (B) is from 15:1 to 1:30, preferably, wherein the weight ratio of component (A) to component (B) is from 10:1 to 1:10, or even more preferably, from 5:1 to 1:5.

[0230] As used herein, the term "fungicide" means a compound that controls, alters, or prevents the growth of fungi. The term "effective fungicide amount" means the amount of such a compound or combination of such compounds that can affect fungal growth. Controlling or altering effects include all deviations from natural development, such as killing, inhibiting, etc., and prevention includes barriers or other defensive structures within or on plants to prevent fungal infection.

[0231] The term "plant" refers to all the tangible parts of a plant, including seeds, seedlings, saplings, roots, tubers, stems, culms, leaves, and fruits.

[0232] The term "plant propagation material" refers to all reproductive parts of a plant, such as seeds or vegetative parts like cuttings and tubers. It includes seeds in the strict sense, as well as roots, fruits, tubers, bulbs, rhizomes, and other parts of the plant.

[0233] As used herein, the term "site" means the place in which or on which a plant grows, or the place where the seeds of a cultivated plant are sown, or the place where the seeds will be placed in the soil. It includes soil, seeds, and seedlings, along with the established vegetation.

[0234] Throughout this document, the term "composition" refers to different mixtures or combinations of components (A) and (B) (including the embodiments defined above), for example, in a single "ready-to-use with water" form, as a combined spray mixture (consisting of individual formulations of these single active ingredients) (e.g., a "tank mix"), and as a combination of these individual active ingredients when applied in a sequential manner (i.e., one after the other, for a suitable short period, such as hours or days). For the purposes of this invention, the order in which components (A) and (B) are applied is not critical.

[0235] The compositions according to the invention are effective against harmful microorganisms (such as microorganisms) that cause plant pathogenic diseases, especially against plant pathogenic fungi and bacteria.

[0236] The compositions of the present invention can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens belonging to the Basidiomycetes, Ascomycetes, Oomycetes and / or Deuteromycetes, Blastodactycetes, Chrytidiomycetes, Glomeromycetes and / or Mucoromycetes.

[0237] This composition effectively controls a broad spectrum of plant diseases, such as leaf pathogens in ornamental plants, turf, vegetables, fields, cereals, and fruit crops.

[0238] These pathogens may include:

[0239] Oomycetes include Phytophthora diseases, such as those caused by *Phytophthora capsici*, *Phytophthora causalosa*, *Phytophthora soybeani*, *Phytophthora fragariae*, *Phytophthora nicotianae*, *Phytophthora cinnamomi*, *Phytophthora citricola*, *Phytophthora citrophthora*, and *Phytophthora erythroseptica*; Pythium diseases, such as those caused by *Pythium cucurbitae*, *Pythium arrhenomanes*, *Pythium gracilis*, *Pythium irregulare*, and *Pythium tertruncatum*; and Downycetes, such as those caused by *Peronospora destructor*, *Peronospora cabbage*, *Peronospora grapei*, *Peronospora sunfloweri*, *Peronospora cucumberi*, and *Albugo*. Diseases caused by Candida, rice downy mildew, and lettuce downy mildew; as well as others, such as those caused by spirulina, Labyrinthula zosterae, Peronosclerospora sorghi, and Sclerospora graminicola;

[0240] Ascomycetes, including diseases such as spot, blight, wilt, or downy mildew and / or rot, such as those caused by: *Stemphylium solani*, *Stagonospora tainanensis*, *Rhizophora oleifera*, *Setosphaeria turcica*, *Pyrenochaeta lycoperisici*, *Stemphylium solani*, *Phoma destructiva*, *Phaeosphaeria herpotrichoides*, *Phaeocryptocus gaeumannii*, *Ophiosphaerella graminicola*, *Ophiobolus graminis*, *Leptosphaeria maculans*, *Hendersonia creberrima*, *Helminthosporium triticirepentis*, *Setosphaeria turcica*, and *Drechslera*. The fungi include: glycines, Didymella bryoniae (watermelon vine blight), Cycloconium oleagineum (olive pea spot), Cladosporium multiflorum, Cyclosporium graminearum, Bipolaris cactivora (dragon fruit black spot), Alternaria sclerotiorum (apple black spot), Pyrenophora tritici-repentis (oat grass sclerotiorum), Alternaria interseptum, Alternaria brassicicola, Alternaria solanacea, and Alternaria tomatophila;Capnodiales include species such as *Septoria glycines*, *Septoria arachidicola*, *Cercospora arachidicola*, *Cercosporella capsellae*, *Cercosporella herpotrichoides*, *Cladosporium carpophilum*, *Cladosporium effusum*, *Passalorafulva*, *Cladosporium oxysporum*, *Dothistroma septosporum*, *Isariopsis clavispora*, *Mycosphaerella graminicola*, and *Mycovellosiella*. *Phaeoisariopsis bataticola*, *Pseudocercospora vitis* (grape brown spot), *Pseudocercospora vitis* (wheat basal rot), *Pseudocercospora var. beetis* (beet leaf spot), *Ramularia collo-cygni* (columnar leaf spot); *Pseudocercospora* (wheat take-all), *Magnaporthe grisea* (rice blast), *Pyrhodosporium* (rice pear spores); *Pseudocercospora* (hazel eastern wilt), *Apiognomonia errabunda*, *Cytospora platani* (hazel eastern wilt), *Pseudocercospora var. gracilis* (soybean northern stem canker), *Disculadestructiva* (destructive spores), *Gnomonia fructicola* (strawberry fructicola), *Pseudocercospora var. gracilis* (grape bitter rot), *Melanconium juglandinum* (walnut black rot), *Phomopsis viticola* (grape viticola), *Sirococcus clavigignenti-juglandacearum* (walnut canker), *Tubakia dryina* (dry spores), *Dicarpella* (dry spores). spp., apple tree rot fungus (Valsa ceratosperma);Others include Actinothyrium graminis, Pea pod spores, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidus, Blumeriella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Acanthoporococcus niger, Epidermophyton spp., Grape bud blight, Geotrichum candida, Gibellina cerealis, Gloeocercospora sorghi), sooty mold bacteria (Gloeodes pomigena), Gloeosporium perennans;Endophytic fungi of dead wheat (Gloeotiniatemulenta), Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, *Pseudomonas aeruginosa*, *Brachystomum spp.*, *Monographella albescens*, *Monographella spp.*, *Naemacyclus* spp., *Ulmus fusarium*, *Paracocytospora brasiliensis*, *Pestalotia rhododendri*, *Petriellidium* spp., *Phyllachora*, *Phymatotrichum*, *Phyllachora pomigena*, *Phymatotrichum* omnivora), Physalospora abdita, Plectosporium tabacinum, Potato skin spot fungus, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulispora sorghi, Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Species of Scedosporium spp., Pomegranate sclerotiorum, Sclerotinia sclerotiorum, Sclerotinia sclerotiorum;Species of the genus *Sclerotium*, including *Typhula ishikariensis*, *Seimatosporium mariae*, *Lepteutypa cupressi*, *Septocyta ruborum*, *Sphaceloma perseae*, *Sporonemaphacidioides*, *Stigmina palmivora*, *Tapesia yallundae*, *Taphrina bullata*, *Thielviopsis basicola*, *Trichoseptoria fructigena*, and *Zygophiala jamaicensis*; powdery mildew, for example, caused by fungi such as *Sphaerotheca fuligena*, *Sphaerotheca fuligena*, *Podospaera macularis*, *Golovinomyces cichoracearum*, and *Leveillula*. Those caused by *Taurica*, *Oidiopsis gossypii*, *Phyllactinia guttata*, and *Oidium arachidis*; molds, such as those caused by *Botrytis cinerea*, *Dothiorella aromatica*, *Diplodia seriata*, *Guignardia bidwellii*, *Botrytis cinerea*, *Botryotinia allii*, *Botryotinia fabae*, *Fusicoccum amygdali*, *Lasiodiplodia theobromae*, *Macrophoma theicola*, *Phyllosticta*, and others. Anthracnose caused by *Cucurbitacearum*; anthracnose, for example, those caused by *Glommerelales* such as *Discocephalus cucurbitacearum*, *Anthracnose cucurbitacearum*, *Anthracnose spp.*, *Glommerelales*, and *Anthracnose gracilis*.And wilt or blight, such as those caused by fungi such as *Atoporhynchus stenoptera*, *Ergacotyle purpureus*, *Fusarium graminearum*, *Fusarium graminearum*, *Fusarium virguliforme*, *Fusarium oxysporum*, *Fusarium globulus*, *Fusarium oxysporum f.sp.cubense*, *Gerlachia nivale*, *Fusarium fusiforme*, *Fusarium graminearum*, *Fusarium graminearum*, *Gerlachia*, *Nectria ramulariae*, *Trichoderma viride*, *Polytrichum erythropterinum*, and *Verticillium theobromae*.

[0241] Basidiomycetes include smut diseases, such as those caused by *Ustilago maydis*, *Smutus oryzae*, *Smutus smutus*, and *Smutus maize*; rust diseases, such as those caused by *Cerotelium fici*, *Chrysomyxa arctostaphyli*, *Coleosporium ipomoeae*, *Hemileia vastatrix*, *Puccinia cacabata*, *Puccinia striiformis*, *Puccinia cryptica*, *Puccinia striiformis*, *Puccinia striiformis* f.sp. Hordei, *Puccinia striiformis* f.sp. Secalis, and *Pucciniastrum coryli*; or *Russales*, such as *Pymnosporangium* and *Gymnosporangium*. These include fungi such as *Juniperi-virginianae*, *Melampsora medusae*, *Phakopsora pachyrhizi*, *Phragmidium mucronatum*, *Physopella ampelosidis*, *Tranzscheliadiscolor*, and *Uromyces viciae-fabae*; as well as other rots and diseases, such as those caused by species of *Cryptococcus*, *Exobasidium vexans*, *Marasmiellus inoderma*, species of *Schefflera*, *Sphacelotheca reiliana*, *Typhula ishikariensis*, *Urocystis agropyri*, *Itersonilia perplexans*, *Corticium invisum*, and *Laetisaria*. Those caused by *Ustilago maydis*, *Waitea circinata*, *Rhizoctonia solani*, *Thanetephorus cucurmeris*, *Entyloma dahliae*, *Entylomella microspora*, *Neovossia moliniae*, and *Tilletia caries*;

[0242] Cladosporidioides, such as Physoderma maydis;

[0243] Mucoromycete class, such as *Choanephora cucurbitarum*, the causal agent of cucumber flower rot; species of the genus *Mucor*; *Rhizopus* spp.

[0244] This includes diseases caused by other species and genera closely related to those listed above.

[0245] In addition to their antifungal activity, these compositions may also have activity against bacteria such as *Pyrus pyrifolia*, *Erwinia caratovora*, *Xanthomonas laurentii*, *Pseudomonas syringae*, *Strptomyces scabies*, and other related species, along with certain protozoa.

[0246] The compositions according to the invention are particularly effective against plant pathogenic fungi belonging to the following classes: Ascomycetes (e.g., *Aureobasidium*, *Cyclocarya*, *Erythrophagus*, *Cyclocarya*, *Cyclocarya*, *Uncaria*); Basidiomycetes (e.g., *Hemileia*, *Rhizoctonia*, *Laminaria*, *Pterygophyllum*, *Ustilago*, *Ustilago*); Deuteromycetes (also known as Deuteromycetes, e.g., *Botrytis*, *Helicobacter*, *Rhizophora*, *Fusarium*, *Syndrome*, *Cercospora*, *Alternaria*, *Pyrophora*, and *Pseudocercospora*); Oomycetes (e.g., *Phytophthora*, *Peronospora*, *Pseudorhyx*, *Euphorbia*, *Plasmodium*, *Pythium*, *Pseudocercospora*, *Monocospora*).

[0247] The compositions according to the invention can be used in useful plant crops including perennial and annual crops, such as berry plants, such as blackberries, blueberries, cranberries, raspberries, and strawberries; cereals, such as barley, maize, millet, oats, rice, rye, sorghum, triticale, and wheat; fiber plants, such as cotton, flax, hemp, jute, and sisal; field crops, such as sugar beets and forage beets, coffee beans, hops, mustard, rapeseed (canola), poppies, sugarcane, sunflowers, tea, and tobacco; fruit trees, such as apples, apricots, avocados, bananas, cherries, citrus fruits, nectarines, peaches, pears, and plums; and grasses, such as Bermuda grass, bluegrass, benjamin grass, centipede grass, sedge, and black clover. Wheatgrass, St. Augustine grass, and zoysia grass; herbs such as basil, borage, chives, coriander, lavender, angelica, mint, oregano, parsley, rosemary, sage, and thyme; legumes such as kidney beans, lentils, peas, and soybeans; nuts such as almonds, cashews, peanuts, hazelnuts, peanuts, pecans, pistachios, and walnuts; palm trees such as oil palms; ornamental plants such as flowers, shrubs, and trees; other trees such as cacao trees, coconut palms, olive trees, and rubber trees; vegetables such as asparagus, eggplant, broccoli, cabbage, carrots, cucumbers, garlic, lettuce, zucchini, melons, okra, onions, peppers, potatoes, squash, rhubarb, spinach, and tomatoes; and grapevines such as grapes.

[0248] Crops should be understood as those that exist naturally, are obtained through conventional breeding methods, or are obtained through genetic engineering. These include crops that possess so-called output traits (such as improved storage stability, higher nutritional value, and improved flavor).

[0249] Crops should be understood to include those that have been conferred tolerance to herbicides (like bromufenoxam) or multiple classes of herbicides (such as ALS-, EPSPS-, GS-, HPPD-, and PPO- inhibitors). Examples of crops that have been conferred tolerance to imidazolinones (e.g., methoxyfenozide) through conventional breeding methods are... Summer Canola. Examples of crops conferred herbicide tolerance through genetic engineering include, for example, glyphosate and glufosinate-resistant maize varieties, which are marketed under trademarks... Herculex and It is available for commercial purchase.

[0250] Crops should also be understood as those that are naturally or have been conferred resistance to pests. This includes plants that are transformed, for example, by using recombinant DNA technology to synthesize one or more selectively acting toxins, such as those known from toxin-producing bacteria. Examples of toxins that can be expressed include delta-endotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins from bacterial colonizing nematodes, and toxins produced by scorpions, arachnids, wasps, and fungi.

[0251] An example of a crop that has been modified to express Bacillus thuringiensis toxin is Bt maize. (Syngenta Seeds). Examples include crops that encode insecticidal resistance and thereby express more than one gene for more than one toxin. (Syngenta Seeds). Crops or their seed material can also be resistant to multiple types of pests (so-called superimposed transgenic events when produced through genetic modification). For example, plants can express insecticidal proteins while simultaneously tolerating herbicides, such as Herculex. (Dow AgroSciences, Pioneer Hi-Bred International)

[0252] The term "useful plant" should be understood to also include useful plants that have been transformed by using recombinant DNA technology to enable them to synthesize one or more selectively acting toxins, such as those known to come from toxin-producing bacteria, especially those of the genus Bacillus.

[0253] Examples of such plants are: (Corn variety expressing CryIA(b) toxin); YieldGard (A maize variety expressing CryIIIB(b1) toxin); YieldGard (Maize variety expressing CryIA(b) and CryIIIB(b1) toxins); (A maize variety expressing the Cry9(c) toxin); Herculex (A maize variety expressing CryIF(a2) toxin and acquiring the enzyme phosphatidylcholine N-acetyltransferase (PAT) to develop resistance to the herbicide glufosinate-ammonium salt); NuCOTN (Cotton variety expressing CryIA(c) toxin); Bolgard (Cotton variety expressing CryIA(c) toxin); Bolgard (Cotton varieties expressing CryIA(c) and CryIIA(b) toxins); (Cotton variety, expressing VIP toxin); (Potato variety that expresses CryIIIA toxin); GT Advantage (GA21 glyphosate resistance) CBAdvantage (Bt11 corn borer (CB) traits), RW (corn rootworm trait) and

[0254] The term "crop" should be understood to also include crop plants that have been transformed using recombinant DNA technology to enable them to synthesize one or more selectively acting toxins, such as those known to originate from toxin-producing bacteria, particularly those of the genus Bacillus.

[0255] Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus spp. Japaneseis; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, or Cry9C, or vegetative insecticidal proteins (Vip), such as Vip1, Vip2, Vip3, or Vip3A; or insecticidal proteins from bacterial colonizing nematodes, such as species of the genus *Photorhabdus* or species of the genus *Xenorhabdus*, such as *Photorhabdus luminescens* and *Xenorhabdus*. Toxins produced by animals, such as scorpion venom, spider venom, bee venom, and other insect-specific neurotoxins; toxins produced by fungi, such as streptotoxins; lectins, such as pea lectin, barley lectin, or snowdrop lectin; agglutinins; protease inhibitors, such as trypsin inhibitors, serine inhibitors, potato glycoproteins, cystatin, and papain inhibitors; ribosome-inactivating proteins (RIPs), such as rici...

Claims

1. A fungicidal composition comprising a mixture of components (A) and (B) as an active ingredient, wherein component (A) is a compound selected from: 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazolyl-4-carboxamide (compound X.29); 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.36); and 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-5-methyl-N-spiro[3,4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37); and Component (B) is a compound selected from the group consisting of: Azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyraclostrobin, fluoxastrobin, benzyl benzoate, fluopyram, isoflucypram, pyrapropoyne, fluinbazin, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam Fluazinam, fluazinam, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin, tricyclazole, quinofumelin, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridine- 3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, N'-[5-bromo-2-methyl-6-(1-methyl) [[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidinium, N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropaneformamide, N,2-di ...phenyl]phenyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-yl]phenyl]phenyl]phenyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-yl]phenyl]phenyl]cyclopropaneformamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-dimethoxy-N-[[4-[54-Oxadiazol-3-yl]phenyl]methyl]propionamide, (Z)-3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoic acid methyl ester, (Z)-3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoic acid methyl ester, (Z)-2-[5-(3-isopropylpyrazol-1-yl)-2-methyl-phenoxy]-3-methoxy-prop-2-enoic acid methyl ester, (Z)-3 methyl methoxy-2-[2-methyl-5-(4-propyltriazol-2-yl)phenoxy]prop-2-enoate, methyl (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol-2-yl]phenoxy]prop-2-enoate, methyl (Z)-2-(5-cyclohexyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate and methyl (Z)-2-(5-cyclopentyl-2-methyl-phenoxy)-3-methoxy-prop-2-enoate; and, The weight ratio of component (A) to component (B) ranges from 100:1 to 1:

100.

2. The antifungal composition according to claim 1, wherein, Component (A) is 2-[(2,6-difluoro-4-pyridinyl)-(2-methoxyacetyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.29).

3. The antifungal composition according to claim 1, wherein, Component (A) is 2-[acetyl-(2,6-difluoro-4-pyridyl)amino]-N-(2,2-dimethylcyclobutyl)-5-methyl-thiazol-4-carboxamide (compound X.36).

4. The antifungal composition according to claim 1, wherein, Component (A) is 2-[acetyl-(2,6-difluoro-4-pyridinyl)amino]-5-methyl-N-spiro[3.4]octane-3-yl-thiazolyl-4-carboxamide (compound X.37).

5. The antifungal composition according to claim 1, wherein, Component (B) is a compound selected from the group consisting of: azoxystrobin, oxadiazon, metyltetraprole, difenoconazole, hexaconazole, propiconazole, prothioconazole, chlorfluazon, benzyl benzoate, butyl morpholine, fluopyram, fluopyram, pyrapropoyne, pyraclostrobin, fluoxastrobin, benzyl-methyl, fluopyram, isoflucypram, pyrapropoyne, fludioxonil, benzylpyridinium chloride, florylpicoxamid, chlorothalonil, mancozeb, dimethomorph, thiamethoxam, fluazinam, fludioxonil, pyraclostrobin, metalaxyl-M, aminopyrifen, captan, ipflufenoquin, quinofumelin. Tricyclazole, quinolones, N-(1-benzyl-1,3-dimethyl-butyl)-8-fluoro-quinoline-3-carboxamide, N-(1-benzyl-3,3,3-trifluoro-1-methyl-propyl)-8-fluoro-quinoline-3-carboxamide, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, and 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline.

6. The fungicidal composition according to any one of claims 1 to 5, wherein the composition is used to control plant pathogenic fungi, wherein the fungi are selected from wheat fermentation spores (Syndrome aegyptium). Zymoseptoria tritici ), gray mold ( Botrytis cinerea Anthracnose of melons ( ) Colletotrichum lagenarium ), Cercospora arachidis ( Cercospora arachidicola ), Inari spores ( Pyricularia oryzae ), Clostridium nivale ( Monographaella nivalis ), beet brown spot fungus ( Cercospora beticola ), round-screwed coelom ( Pyrenophora teres Alternaria solanacearum ( Alternaria solani ), Sclerotinia sclerotiorum ( Sclerotinia sclerotiorum ), wheat powdery mildew fungus ( Blumeria graminis ), wheat rust fungus ( Puccinia recondita ) or yam bean rust fungus ( Phakopsora pachyrhizi ).

7. The antifungal composition according to any one of claims 1 to 5, wherein, The weight ratio of component (A) to component (B) ranges from 20:1 to 1:

40.

8. The antifungal composition according to any one of claims 1 to 5, wherein, The weight ratio of component (A) to component (B) ranges from 12:1 to 1:

25.

9. The antifungal composition according to any one of claims 1 to 5, wherein, The weight ratio of component (A) to component (B) ranges from 5:1 to 1:

15.

10. The antifungal composition according to any one of claims 1 to 5, wherein, The weight ratio of component (A) to component (B) ranges from 2:1 to 1:

5.

11. The antifungal composition according to any one of claims 1 to 5, wherein, The composition comprises one or more additional pest control agents selected from the group consisting of fungicides, insecticides, bactericides, acaricides, and biological agents, wherein: a) The fungicide is selected from tebuconazole, fluazinam, benzovindiflubenzuron, fluopyram, benzalkonium chloride, benzalkonium chloride-M (refined benzalkonium chloride), furazolidone, metalaxyl, metalaxyl-M, doxycycline, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methylformamidin, N'-[4-(4,5-dichloro-thiazol-2-yloxy)-2,5-dimethyl-phenyl]-N-ethyl-N-methylformamidin, N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]- 2,5-Dimethyl-phenyl]-N-ethyl-N-methyl-formamidin, ethamazol, 3'-chloro-2-methoxy-N-[(3RS)-tetrahydro-2-oxofuran-3-yl]acetyl-2',6'-dimethylaniline (Imidacloprid), pyrimethanil, pyrimethanil, dithiamethoxam, aureomycin, blastomycin-S, chloronitrobenzene, pentachloronitrobenzene, TCNB, methyl thiophanate, benomyl, 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, fluopyram, thiocyanate benzamide, sulfadiazine, benomyl, carbendazim, carbendazim Hydrochloride, clofenazole, malathion, thiabendazole, thiophanate-methyl, bensulfuron-methyl, mefenoxam, thiabendazole, aramacin, cymoxanil, benzoyl permethrin, aramacin-S-methyl, pyraclostrobin, 3-iodo-2-propynyl n-butylcarbamate (IPBC), piperazine, cymoxanil, trifluoromethoxycarb, 3-(difluoromethyl)-N-(7-fluoro-1,1,3,3-tetramethyl-indan-4-yl)-1-methyl-pyrazole-4-carboxamide, diclofenac, N-[(5-chloro-2-isopropyl-phenyl)methyl]-N-cyclopropyl-3- (Difluoromethyl)-5-fluoro-1-methylpyrazole-4-carboxamide, N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-[(2-isopropylphenyl)methyl]-1-methylpyrazole-4-carboxamide, cyproconazole, chlorothalonil, flumorph, quinoline copper, cymoxanil, cyazofamid, cymoxanil, fluoxastrobin, thiamethoxam, ethoxysulfuron, iprodione, procymidone, fenvalerate, sulfadiazine, pentazocide, azoxystrobin, 2,6-dimethyl-[1,4]dithiazolinone[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-Tetraketone, Frucium oxychloride, Mancozeb, Ferrous sulfate, Mancozeb, Mancozeb, Mancozeb, Mancozeb-zinc, Sodium mancozeb, Methyl zineb, Frucium oxychloride, Verbam, Zineb, Zinc thiram, Dimethyl disulfide, Isoprothiolane, Thiazolamide, Tris(ethyl phosphonic acid), Aluminum tris(ethyl phosphonic acid), Iodomethyl, Methyl isothiocyanate, Cyclomethrin, Mefenoxam, Validamycin, (2RS)-2-bromo-2-(bromomethyl)glutaronitrile (bromomethrin), Polyfop-methyl, Dodecyl guanidine acetate, Biguanidine octyl salt, Biguanidine octylamine, Biguanidine octylamine triacetate, Kasugamycin, Mefenoxam, Cyclomethrin, Hymexazol, Imazalil, Oxadiazon, Isoprothiolane, Prochloraz, Fluopyram, Imidacloprid, Boswellia carterii Aldo Mixture, Calcium Polysulfide, Copper Acetate, Copper Carbonate, Copper Hydroxide, Copper Naphthenate, Copper Oleate, Copper Oxide, Copper Hydroxyquinoline, Copper Silicate, Copper Sulfate, Copper Fatty Acid, Cuprous Oxychloride, Sulfur, Rice Blast Radix, Azoxystrobin (Bacteriocin), Thiapaveril, Fenoxac, Dimethomorph, Dimethomorph, Butylmorpholine, Tridemorpholine, Dodecylmorpholine, Ethiocarb, Triphenyltin Acetate, Triphenyltin Hydroxide, Carbendazim, Oxytetracycline, Dimethomorph, Oxytetracycline, m-Phenylephrine, p-Phenylephrine, Tribromophenol (TBP), 2-[2-[(7,8-difluoro-2-methyl-3-quinolinyl)oxy]-6-fluoro-phenyl]propane-2-ol, 2-[2-fluoro -6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]phenyl]propane-2-ol, cycloflufenicol, furazolidone, oxadixyl, fluopyram, cymoxanil, isothiazine, seed dressing agent, fludioxonil, pendimethalin, cyproconazole, isopyram, dimethoate, captan, phosmet, benzoyl permethrin, benzyl benzoate, osthol, polyoxin D, BLAD, chitosan, cyanamide, captan, 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide, bifenthiophanate-methyl, fluopyram, furazolidone, pyrazolenaphthalene, pendimethalin, pyrimethanil, fluopyram, fluoxastrobin, acetamiprid Pyridaben, pyridaben, pyridabenoxime, cyazofamid, fluopyram, diflubenzuron, chloropyrimidinol, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, pyraclostrobin, sclerotinib, quinolones, propoxyquinoline, quinoxaline, 4,4,5-trifluoro-3,3-dimethyl-1-(3-quinolinyl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(3-quinolinyl)isoquinoline, 5-fluoro-3,3,4,4-tetramethyl-1-(3-quinolinyl)isoquinoline, 9-fluoro-2,2-dimethyl-5-(3-quinolinyl)-3H-1,4-benzoxazine, isobutylethoxyquinoline, spirocycline, (E)-N-methyl-2-[2-(2,5-Dimethylphenoxymethyl)phenyl]-2-methoxy-iminoacetamide, azoxystrobin, eugenol, fenamidoxime, fenamidoxime, fluopyram, flupyraclostrobin, fenamidoxime, mandesbin, benzylamine, pyraclostrobin, fenamidoxime, azoxystrobin, pyraclostrobin, chlorpyrifos, fenamidoxime, indazole, thiamethoxam, parathion, butyl-3-ynylN-[6-[[(Z)-[(1-methyltetrazole-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridine [Base] Carbamate, Dazomet, Isothiazamide, Thiamethoxam, Thifluzamide, Benzylthiocyanate (TCMTB), Thiosylsilazole, Benzoylthiocyanate, Antifungal, Tricyclazole, (.+-.)-cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol (Cyclopyrazole), 1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propane-2-ol, 2-(1-tert-butyl)-1-(2-chlorophenyl)- 3-(1,2,4-triazol-1-yl)-propane-2-ol (TCDP), (N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidinium), azaconazole, bifenthrin, furazolidone, clomiphene, cyclophosphamide, difenoconazole, tebuconazole, tebuconazole-M, flutriafol, eticonazole, cyproconazole, fluquinazole, flusilazole, fenazol, hexaconazole, imidacloprid, tebuconazole, tebuconazole, propiconazole, fenproprid Prothioconazole, chlorfenapyr, silfluzazole, tebuconazole, tetraflufenazole, triadimefon, triadimefon, imidazolimide, tebuconazole, 2-[[(1R,5S)-5-[(4-fluorophenyl)methyl]-1-hydroxy-2,2-dimethyl-cyclopentyl]methyl]-4H-1,2,4-triazol-3-thione, 2-[[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)ethyleneoxy-2-yl]methyl]-4H-1,2,4-triazol-3-thione, azoxystrobin, isopyram, cymoxanil, and Timorx Gold. TM ; b) The insecticides mentioned are selected from abamectin, chlorfenapyr, acetamiprid, chlorpyrifos, azadirachtin, bifenthrin, rice lice controlclofen, carbaryl, batan, chlorantraniliprole, brofenoxuron, flufenoxuron, methyl chlorpyrifos, cyclone dichlorvos, thiamethoxam, cypermethrin, β-cypermethrin, deltamethrin, lambda-cyhalothrin, lamivudine, deltamethrin, difenoconazole, diazinon, diflubenzuron, tetrafluoromethrin, dimethoate, dinotefuran, benzyl benzoate, emamectin, cypermethrin, acetamiprid, benzyl thiophanate-methyl, fenpropathrin, fenvalerate, cypermethrin, flufenoxuron, flufenoxuron, flufenoxuron, t-flufenoxuron, pyrimethanil. Flufenoxam, terbufos, chlorfenapyr, flufenoxuron, flufenoxuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, cyfluthrin, methomyl, tebufenozide, methoxyfenozide, acetamiprid, nifediazole, difenourea, polyfluorourea, nematicide, permethrin, pirimicarb, profenofos, pymetrozine, pyrethroid, acetamiprid, flufenoxuron, pyrethroid, pyrethroid, flufenoxuron, pyrimethanil, fenpropathrin, rotenone, rifenoxuron, spinosad, spinosad, spirotetramat, thiophanate-methyl, tebufenozide, flufenoxuron, heptafluthrin, thiamethoxam, thiamethoxam, thiamethoxam, thiamethoxam, tetrabromodiphenyl ether, pymetrozine, and chlorpyrifos; c) The bactericide is selected from streptomycin, chlorothalonil, and oxaquinic acid; d) The acaricides mentioned are selected from sulfadiazine, amitraz, bifenazate, fenpyroximate, diflubenzuron, chlorfenapyr, cypermethrin, tricyclic tin, chlorfenapyr, chlorfenapyr, chlorfenapyr, etoxazole, quinfenoxam, fenbutatin, cypermethrin, pyridaben, thiamethoxam, chlorfenapyr, chlorfenapyr, pyridaben, spirodiclofen, spirodiclofen, and pyridaben; e) The biological reagents are selected from Bacillus thuringiensis, Bacillus thuringiensis δ endotoxin, baculoviruses, entomopathogenic bacteria, entomopathogenic viruses, and entomopathogenic fungi.

12. The antifungal composition according to any one of claims 1 to 5, wherein, The composition further comprises an agriculturally acceptable carrier.

13. The antifungal composition according to claim 12, wherein, The composition further comprises, optionally, a surfactant.

14. The antifungal composition according to claim 12, wherein, The composition further comprises optional formulation adjuvants.

15. The antifungal composition according to claim 13, wherein, The composition further comprises optional formulation adjuvants.

16. A method for controlling or preventing plant pathogenic fungi on a useful plant, the method comprising applying a fungicidal composition as defined in any one of claims 1 to 15 to the useful plant or its location.

17. The method of claim 16, further comprising applying the fungicidal composition as defined in any one of claims 1 to 15 to the propagation material of the useful plant.

Citation Information

Patent Citations

  • Novel bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin

    EP0367474A1

  • Insecticidal toxines, genes coding therefor, antibodies binding them, transgenic plant cells and plants expressing these toxines

    EP0374753A2

  • Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins

    EP0401979A2

  • Larvicidal lectins and plant insect resistance based thereon

    EP0427529A1

  • Modifying plants by genetic engineering to combat or control insects

    EP0451878A1